MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)
$94.51 -1.2 (-1.2538%)
Analysed MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) News Sources
2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term
19-04-2026
fool.com
Four Biotech Stocks Near Buy Points As Earnings Season Kicks In
17-04-2026
yahoo.com
Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?
17-04-2026
yahoo.com
Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi‑Year Share Price Run?
13-04-2026
yahoo.com
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13-04-2026
yahoo.com
Prediction: Buying This Biotech Stock Today Could Set You Up for Life
13-04-2026
fool.com
Egetis Appoints Tiago Nunes as Chief Medical Officer
09-04-2026
yahoo.com
Mirum (MIRM) Q2 2025 Earnings Call Transcript
01-04-2026
fool.com
Mirum (MIRM) Q1 2025 Earnings Call Transcript
01-04-2026
fool.com
Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?
01-04-2026
yahoo.com
What is the current price of MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)?
The current price of MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) is $94.51.
MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) absolute price change since previous trading day?
The absolute price change of MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) since the previous trading day is $-1.2.
MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) percentage price change since previous trading day?
The percentage price change of MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) since the previous trading day is -1.2538%.
What is the most recent average sentiment score for MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)?
The most recent average sentiment score for MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)?
The most recent sentiment for MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) is .
SEC-8K** Filing Available For MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.